People with Asthma Who Take Weight Loss Drug Semaglutide Have Fewer Attacks, Study Shows The medication semaglutide, traditionally prescribed for weight loss and diabetes management, has been found to reduce asthma attacks in patients.
This breakthrough was discovered through a study conducted on existing users of the drug, which is sold under brand names such as Ozempic or Wegovy.
Historically, asthma management has focused on bronchodilators and corticosteroids to alleviate symptoms. However, the study's findings suggest that semaglutide may be a game changer in respiratory care.